The first doses of newly approved vaccines for coronavirus disease 2019 (COVID-19) are slowly rolling out to the public, but manufacturer concern about liability for potential side effects could reduce availability in some countries. In addition, the lack of an effective compensation system raises fairness concerns for those who might suffer adverse reactions, and it could discourage people from rolling up their sleeves for the greater good. The RAND Institute for Civil Justice and the RAND Kenneth R. Feinberg Center for Catastrophic Risk Management and Compensation convened a virtual event to discuss (1) the challenges in facilitating the global distribution of COVID-19 vaccines and (2) how to prevent liability and compensation concerns from affecting the vaccine supply chain and the uptake of the vaccine by the public.

Research conducted by

This report is part of the RAND Corporation presentation series. RAND presentations may include briefings related to a body of RAND research, videos of congressional testimonies, and a multimedia presentation on a topic or RAND capability. All RAND presentations represent RAND's commitment to quality and objectivity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.